{
    "symbol": "SCRIBE",
    "slug": "scribe",
    "display_name": "SCRIBE",
    "category": "stocks",
    "region": "US",
    "description": null,
    "url": "https://finscans.com/asset/scribe",
    "lang": "en",
    "as_of": "2026-07-24T03:25:02+00:00",
    "stats_30d": {
        "total_signals": 1,
        "bullish": 1,
        "bearish": 0,
        "neutral": 0,
        "explicit": 1,
        "inferred": 0,
        "avg_impact": 8,
        "avg_confidence": 85,
        "last_signal_at": "2026-07-24 03:32:29",
        "article_count": 1
    },
    "top_catalysts": [
        {
            "text": "Upsized IPO with shares priced above the high end of the marketed range",
            "count": 1
        },
        {
            "text": "Validation from Eli Lilly as a major strategic investor",
            "count": 1
        }
    ],
    "top_risk_factors": [
        {
            "text": "Post-IPO lockup expiration could trigger insider selling pressure",
            "count": 1
        },
        {
            "text": "Broader biotech sector rotation away from high-risk early-stage names",
            "count": 1
        }
    ],
    "recent_signals": [
        {
            "signal_at": "2026-07-24 03:32:29",
            "sentiment": "Bullish",
            "impact_score": 8,
            "confidence_score": 85,
            "mention_type": "explicit",
            "timeframe": "short-term",
            "region": "US",
            "reasoning": "Scribe Therapeutics raised $128.7 million in an upsized IPO, pricing above the initial range. Strong institutional demand and the backing of Eli Lilly lifted the stock in early trading, reflecting bullish sentiment for the newly public biotech.",
            "article": {
                "title": "Scribe Raises $128.7M in Upsized IPO Backed by Eli Lilly",
                "url": "https://finscans.com/news/scribe-raises-1287m-in-upsized-ipo-backed-by-eli-lilly"
            }
        }
    ]
}